Madrigal Pharmaceuticals Aktie
296,30
EUR
+2,50
EUR
+0,85
%
311,00
USD
+0,67
USD
+0,22
%
Madrigal Pharmaceuticals Aktie Analyse
10.06.19 | Madrigal Pharmaceuticals Buy | B. Riley FBR | |
28.02.19 | Madrigal Pharmaceuticals Buy | H.C. Wainwright & Co. | |
14.12.18 | Madrigal Pharmaceuticals Outperform | Wolfe Research | |
12.12.18 | Madrigal Pharmaceuticals Neutral | B. Riley FBR | |
01.06.18 | Madrigal Pharmaceuticals Outperform | Oppenheimer & Co. Inc. | |
01.06.18 | Madrigal Pharmaceuticals Buy | H.C. Wainwright & Co. | |
30.01.18 | Madrigal Pharmaceuticals Buy | H.C. Wainwright & Co. | |
06.12.17 | Madrigal Pharmaceuticals Buy | H.C. Wainwright & Co. | |
Werbung
|
|||
29.11.17 | Madrigal Pharmaceuticals Buy | H.C. Wainwright & Co. |